NO20030495L - Peptider som presenteres av celler - Google Patents
Peptider som presenteres av cellerInfo
- Publication number
- NO20030495L NO20030495L NO20030495A NO20030495A NO20030495L NO 20030495 L NO20030495 L NO 20030495L NO 20030495 A NO20030495 A NO 20030495A NO 20030495 A NO20030495 A NO 20030495A NO 20030495 L NO20030495 L NO 20030495L
- Authority
- NO
- Norway
- Prior art keywords
- peptides
- cells
- determination
- peptides presented
- relates
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 238000004949 mass spectrometry Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000004071 biological effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 230000005847 immunogenicity Effects 0.000 abstract 1
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
- G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Optics & Photonics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0018901.9A GB0018901D0 (en) | 2000-08-03 | 2000-08-03 | Peptides presented by cells |
| PCT/EP2001/008625 WO2002012899A2 (en) | 2000-08-03 | 2001-07-26 | Peptides presented by cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20030495L true NO20030495L (no) | 2003-01-31 |
| NO20030495D0 NO20030495D0 (no) | 2003-01-31 |
Family
ID=9896790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20030495A NO20030495D0 (no) | 2000-08-03 | 2003-01-31 | Peptider som presenteres av celler |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20030171290A1 (no) |
| EP (1) | EP1305343B1 (no) |
| JP (1) | JP2004506202A (no) |
| KR (1) | KR20030037272A (no) |
| CN (1) | CN1511164A (no) |
| AT (1) | ATE306498T1 (no) |
| AU (1) | AU2001283958A1 (no) |
| BR (1) | BR0112925A (no) |
| CA (1) | CA2417767A1 (no) |
| CZ (1) | CZ2003464A3 (no) |
| DE (1) | DE60114018T2 (no) |
| GB (1) | GB0018901D0 (no) |
| HU (1) | HUP0301581A2 (no) |
| MX (1) | MXPA03000901A (no) |
| NO (1) | NO20030495D0 (no) |
| PL (1) | PL358874A1 (no) |
| RU (1) | RU2003105806A (no) |
| SK (1) | SK1982003A3 (no) |
| WO (1) | WO2002012899A2 (no) |
| ZA (1) | ZA200301637B (no) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001292778A1 (en) * | 2000-09-18 | 2002-03-26 | Genzyme Corporation | Method to identify therapeutic antibody targets associated with a therapeutic response |
| WO2002103360A1 (fr) * | 2001-06-19 | 2002-12-27 | Suntory Limited | Methode d'analyse d'une proteine apparaissant dans une cellule ou d'une substance interagissant avec la proteine |
| EP2481422A3 (en) * | 2003-09-03 | 2013-04-03 | Dendritherapeutics, Inc. | Multiplex vaccines |
| JP4948174B2 (ja) | 2003-10-16 | 2012-06-06 | マイクロメット アクツィエン ゲゼルシャフト | 多重特異的脱免疫ｃｄ３−結合物質 |
| EP1982176A1 (en) * | 2006-01-30 | 2008-10-22 | Dako Denmark A/S | High-speed quantification of antigen specific t-cells in whole blood by flow cytometry |
| WO2008116468A2 (en) | 2007-03-26 | 2008-10-02 | Dako Denmark A/S | Mhc peptide complexes and uses thereof in infectious diseases |
| EP3620465B1 (en) | 2007-07-03 | 2025-02-19 | Dako Denmark A/S | Improved methods for generation, labeling and use of mhc multimers |
| WO2009039854A2 (en) | 2007-09-27 | 2009-04-02 | Dako Denmark A/S | Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics |
| DK2254592T3 (da) | 2008-02-28 | 2019-09-09 | Dako Denmark As | MHC-multimerer til Borrelia-diagnostik og sygdom |
| WO2010009735A2 (en) * | 2008-07-23 | 2010-01-28 | Dako Denmark A/S | Combinatorial analysis and repair |
| GB0817244D0 (en) * | 2008-09-20 | 2008-10-29 | Univ Cardiff | Use of a protein kinase inhibitor to detect immune cells, such as T cells |
| US11992518B2 (en) | 2008-10-02 | 2024-05-28 | Agilent Technologies, Inc. | Molecular vaccines for infectious disease |
| WO2010037402A1 (en) | 2008-10-02 | 2010-04-08 | Dako Denmark A/S | Molecular vaccines for infectious disease |
| JP5822841B2 (ja) | 2009-11-05 | 2015-11-24 | テバ・ファーマシューティカルズ・オーストラリア・ピーティワイ・リミテッド | 変異型のｋｒａｓまたはｂｒａｆ遺伝子を含むがんの治療 |
| US20150017136A1 (en) * | 2013-07-15 | 2015-01-15 | Cellectis | Methods for engineering allogeneic and highly active t cell for immunotherapy |
| MX2015015638A (es) * | 2013-05-13 | 2016-10-28 | Cellectis | Metodos para diseñar celulas t altamente activas para inmunoterapia. |
| CA3008641A1 (en) | 2015-12-16 | 2017-06-22 | Gritstone Oncology, Inc. | Neoantigen identification, manufacture, and use |
| CN108473973A (zh) * | 2016-09-30 | 2018-08-31 | 赛尔莱克斯生命科学公司 | 包含负载蛋白的外泌体的组合物以及制备和递送该组合物的方法 |
| EP3694532B1 (en) | 2017-10-10 | 2025-02-26 | Gritstone bio, Inc. | Neoantigen identification using hotspots |
| WO2019104203A1 (en) | 2017-11-22 | 2019-05-31 | Gritstone Oncology, Inc. | Reducing junction epitope presentation for neoantigens |
| WO2020127222A2 (en) | 2018-12-17 | 2020-06-25 | Immudex Aps | Panel comprising borrelia mhc multimers |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69833755T2 (de) * | 1997-05-21 | 2006-12-28 | Biovation Ltd. | Verfahren zur herstellung von nicht-immunogenen proteinen |
| EP1051432B1 (en) * | 1998-12-08 | 2007-01-24 | Biovation Limited | Method for reducing immunogenicity of proteins |
| AU4676500A (en) * | 1999-04-28 | 2000-11-10 | Northwestern University | Localization of major peptide autoepitopes for nucleosome specific t cells of systemic lupus erythematosus |
-
2000
- 2000-08-03 GB GBGB0018901.9A patent/GB0018901D0/en not_active Ceased
-
2001
- 2001-07-26 EP EP01962874A patent/EP1305343B1/en not_active Expired - Lifetime
- 2001-07-26 BR BR0112925-2A patent/BR0112925A/pt not_active IP Right Cessation
- 2001-07-26 CN CNA01813694XA patent/CN1511164A/zh active Pending
- 2001-07-26 KR KR10-2003-7001568A patent/KR20030037272A/ko not_active Withdrawn
- 2001-07-26 RU RU2003105806/13A patent/RU2003105806A/ru not_active Application Discontinuation
- 2001-07-26 DE DE60114018T patent/DE60114018T2/de not_active Expired - Lifetime
- 2001-07-26 AU AU2001283958A patent/AU2001283958A1/en not_active Abandoned
- 2001-07-26 MX MXPA03000901A patent/MXPA03000901A/es unknown
- 2001-07-26 PL PL01358874A patent/PL358874A1/xx unknown
- 2001-07-26 AT AT01962874T patent/ATE306498T1/de not_active IP Right Cessation
- 2001-07-26 US US10/343,443 patent/US20030171290A1/en not_active Abandoned
- 2001-07-26 WO PCT/EP2001/008625 patent/WO2002012899A2/en not_active Ceased
- 2001-07-26 SK SK198-2003A patent/SK1982003A3/sk not_active Application Discontinuation
- 2001-07-26 JP JP2002517532A patent/JP2004506202A/ja active Pending
- 2001-07-26 CA CA002417767A patent/CA2417767A1/en not_active Abandoned
- 2001-07-26 HU HU0301581A patent/HUP0301581A2/hu unknown
- 2001-07-26 CZ CZ2003464A patent/CZ2003464A3/cs unknown
-
2003
- 2003-01-31 NO NO20030495A patent/NO20030495D0/no unknown
- 2003-02-27 ZA ZA200301637A patent/ZA200301637B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0301581A2 (hu) | 2003-08-28 |
| JP2004506202A (ja) | 2004-02-26 |
| CA2417767A1 (en) | 2002-02-14 |
| SK1982003A3 (en) | 2003-08-05 |
| EP1305343A2 (en) | 2003-05-02 |
| KR20030037272A (ko) | 2003-05-12 |
| DE60114018D1 (de) | 2006-02-23 |
| US20030171290A1 (en) | 2003-09-11 |
| AU2001283958A1 (en) | 2002-02-18 |
| EP1305343B1 (en) | 2005-10-12 |
| BR0112925A (pt) | 2003-08-26 |
| PL358874A1 (en) | 2004-08-23 |
| NO20030495D0 (no) | 2003-01-31 |
| RU2003105806A (ru) | 2004-07-20 |
| WO2002012899A2 (en) | 2002-02-14 |
| ATE306498T1 (de) | 2005-10-15 |
| DE60114018T2 (de) | 2006-06-29 |
| CN1511164A (zh) | 2004-07-07 |
| ZA200301637B (en) | 2004-02-03 |
| WO2002012899A3 (en) | 2002-11-07 |
| MXPA03000901A (es) | 2003-06-24 |
| GB0018901D0 (en) | 2000-09-20 |
| CZ2003464A3 (cs) | 2003-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20030495L (no) | Peptider som presenteres av celler | |
| EP2338333A3 (en) | Glycopegylation methods and proteins/peptides produced by the methods | |
| ATE464067T1 (de) | Bindegewebs wachstumsfaktor (ctgf) | |
| ATE380822T1 (de) | Funf-helix protein | |
| AR038568A1 (es) | Anticuerpos anti-a beta y su uso | |
| WO2002002783A3 (en) | Expression vectors | |
| WO1996034107A3 (en) | Antiviral proteins, dna coding sequences therefor, and uses thereof | |
| WO2004007547A3 (en) | Truncated tau proteins | |
| EP2275554A3 (en) | Neisserial antigenic peptides | |
| DE60313659D1 (de) | Borrelidin-derivate und ihre medizinische anwendung | |
| CY1117746T1 (el) | Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna | |
| WO2004081033A3 (en) | Synthesis of proteins by cell-free protein expression | |
| WO2001029220A3 (en) | Mage-a12 antigenic peptides and uses thereof | |
| AU2001238064A1 (en) | 18477, a human protein kinase and uses therefor | |
| DE69836333D1 (de) | Neisseria lactoferrin-bindendes protein | |
| WO2002074921A3 (en) | Methods for isolating proteins expressed by dendritic cells | |
| NO992531L (no) | Fremgangsmåter ved fremstilling av rekombinant protein | |
| WO1998051782A3 (en) | Human 3-hydroxyisobutyryl-coenzyme a hydrolase | |
| WO2005044849A3 (en) | Lp mammalian proteins; related reagents | |
| WO2003025197A3 (en) | Mutant sh3-binding protein compositions and methods | |
| WO1998041538A3 (en) | Novel human cytokine/steroid receptor protein | |
| WO2003099209A3 (en) | Compositions and methods for screening and identifying anti-hcv agents | |
| WO2001018212A3 (en) | Mycobacterium paratuberculosis-specific antigens and their diagnostic uses | |
| ATE338764T1 (de) | Vorrichtung von peptid- oder proteindarstellung, verfahren zu deren herstellung und deren verwendung | |
| WO2002063009A8 (en) | Lp mammalian proteins; related reagents |